Skip to main content

Unresectable mCRC: Final survival outcomes with first-line trifluridine/tipiracil plus bevacizumab in TASCO1

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Unresectable mCRC: Final survival outcomes with first-line trifluridine/tipiracil plus bevacizumab in TASCO1

User login

Username

Password

Reset your password

Type	Lead	score